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Abstract 
The overall aim of this thesis was to investigate the uncertainties in the dose distribution 
determined at the treatment planning stage. The work has been based on the main hypothesis that 
the way of determining dose at the stage of treatment planning can be improved to such an extent 
that it affects the risk-benefit assessment. Photon beam treatments of breast and lung cancer were 
considered, i.e. treatments that are delivered to a region of the body that includes lung tissue. 
Density inhomogenities are a challenge for the clinical dose calculation algorithms (DCAs). 
Another challenge for the loco-regional breast cancer treatments are the adjacent fields where the 
jaw positioning uncertainty may influence the uniformity of the dose distribution. 
Different clinical DCAs were compared regarding their ability to calculate dose to lung (organ at 
risk). The differences were quantified in terms of normal tissue complication probabilities 
(NTCP) in Paper I. This study showed that the uncertainties in clinical DCAs can be of the same 
magnitude as the uncertainties of published NTCP model parameters. Adjusted NTCP model 
parameters were retrieved to avoid introduction of this additional uncertainty. The performance 
of clinical DCAs regarding calculation of target dose for the case of stereotactic (small fields) 
lung cancer treatments was compared to Monte Carlo (MC) calculations in Paper II. The 
principle-based DCA Acuros XB (Varian, Eclipse) was found to comply better with MC than the 
pencil-beam based analytical anisotropic algorithm (AAA) included in the study. The clinical 
impact of the transition from the AAA to Acuros XB was discussed. In paper III and IV breast 
cancer treatments were studied. The impact of jaw positioning uncertainty on the dose distribution 
in the case of adjacent fields was investigated in paper III. The effect on lung tissue was small 
whereas hotspots were found in soft tissue with unknown risks for plexus brachialis. In paper IV 
the performance of different clinical dose calculation algorithms in lung tissue with low density 
due to the breathing adaptive technique of deep inspiration breath hold (DIBH) was investigated. 
The clinical impact of the transition from AAA to Acuros XB was discussed. Acuros XB was 
compared to MC for the lowest lung density identified and the reliability of the Acuros XB 
calculation was confirmed. The clinical impact of the transition from AAA to Acuros XB was 
quantified for dose planning criteria based on different lung DVH parameters. 
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